| Identification |
| Name: | VERAPAMILETHYL METHANETHIOSULFONATE, BROMIDE |
| Synonyms: | VERAPAMILETHYL METHANETHIOSULFONATE, BROMIDE;d-Cyano-N-[2-(3,4-dimethoxyphenyl)ethyl]-3,4-dimethoxy-N-methyl-d-(1-methylethyl)-N-[2-[(methylsulfonyl)thio]ethyl]benzenebutanaminium Bromide |
| CAS: | 353270-25-4 |
| Molecular Formula: | C30H45BrN2O6S2 |
| Molecular Weight: | 673.72 |
| InChI: | InChI=1/C30H45N2O6S2.BrH/c1-23(2)30(22-31,25-11-13-27(36-5)29(21-25)38-7)15-9-16-32(3,18-19-39-40(8,33)34)17-14-24-10-12-26(35-4)28(20-24)37-6;/h10-13,20-21,23H,9,14-19H2,1-8H3;1H/q+1;/p-1 |
| Molecular Structure: |
![(C30H45BrN2O6S2) VERAPAMILETHYL METHANETHIOSULFONATE, BROMIDE;d-Cyano-N-[2-(3,4-dimethoxyphenyl)ethyl]-3,4-dimethoxy-...](https://img.guidechem.com/structure/353270-25-4.gif) |
| Properties |
| Usage: | An analog of Verapamil. P Glycoprotein drug binding domain verapamil methanethiosulfonate. Useful for mapping the pore region of L-type calcium channels and Kv1.3 potassium channels |
| Safety Data |
| |
 |
